Merck to receive $269 million for production of COVID-19 vaccines and drugs
Merck KGaA & Co. fundamentals
For this year the company, located in Kenilworth revenue will be around 52.51 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 47.99 billion USD.
Historical revenues and results Merck KGaA & Co plus estimates 2020
The analysts expect for 2021 a net profit of 16.58 billion USD. The majority of the analysts expects for this year a profit per share of 6.55 USD. The price/earnings-ratio therefore equals 11.02.
Huge dividend Merck KGaA & Co
Per share the analysts are expecting a dividend of 2.57 USD per share. Merck KGaA & Co's dividend yield thus equals 3.56 percent. The average dividend yield of the pharmaceutical companies equals a moderate 0.38 percent.Recent target prices around 92 USD
The most recent recommendations for the pharmaceutical company are from Cowen and Company, RBC Capital Markets and UBS .Merck KGaA & Co's market capitalization is based on the number of outstanding shares around 183.24 billion USD. The Merck KGaA & Co stock was the past 12 months quite unstable. Since last March the stock is 9 percent lower. This year the stock price moved between 65 and 88 dollar.
Historical stock prices Merck KGaA & Co2007-2021
Click here for dividend Merck & Co. On Thursday the stock closed at 72.17 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
